Use of enoxaparin for the chronically anticoagulated patient before and after procedures

J M Spandorfer; S Lynch; H H Weitz; S Fertel; G J Merli

doi:10.1016/s0002-9149(99)00341-0

Use of enoxaparin for the chronically anticoagulated patient before and after procedures

Am J Cardiol. 1999 Aug 15;84(4):478-80, A10. doi: 10.1016/s0002-9149(99)00341-0.

Authors

J M Spandorfer¹, S Lynch, H H Weitz, S Fertel, G J Merli

Affiliation

¹ Division of Internal Medicine, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

PMID: 10468095
DOI: 10.1016/s0002-9149(99)00341-0

Abstract

Patients who require chronic anticoagulation and a procedure have been traditionally managed either by stopping warfarin and starting intravenous standard heparin or by adjusted dose subcutaneous standard heparin or taken off all anticoagulation for a week before the procedure. Enoxaparin may be useful as an alternative method of anticoagulation, avoiding hospitalization and the need for frequent monitoring.

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Anticoagulants / therapeutic use*
Cardiac Surgical Procedures / adverse effects
Enoxaparin / therapeutic use*
Female
Humans
Male
Middle Aged
Prospective Studies
Risk Factors
Surveys and Questionnaires
Thromboembolism / blood
Thromboembolism / etiology
Thromboembolism / prevention & control*
Treatment Outcome
Warfarin / therapeutic use*

Substances

Anticoagulants
Enoxaparin
Warfarin